![](/wp-content/themes/basic-child/images/print.png)
Equine Lyme
![horse-5628882_1280 horse-5628882_1280](https://lymediseaseassociation.org/wp-content/uploads/2024/02/horse-5628882_1280.jpg)
EquiManagement published the Disease Du Jour podcast, “Ep. 126: Lyme Disease with Dr. Toby Pinn-Woodcock.” In this podcast, Dr. Pinn-Woodcock, DVM, DACVIM, provides a broad overview of Lyme disease in equines.
EquiManagement published the Disease Du Jour podcast, “Ep. 126: Lyme Disease with Dr. Toby Pinn-Woodcock.” In this podcast, Dr. Pinn-Woodcock, DVM, DACVIM, provides a broad overview of Lyme disease in equines.
Fox News, Melissa Rudy, 12.10.2023, reports on “Deadly Rocky Mountain spotted fever outbreak in California likely came from Mexico, CDC says.” The Centers for Disease Control and Prevention (CDC) issued a health advisory on 12.08.2023 advising of an outbreak of Rocky Mountain spotted fever (RMSF) southern California which has hospitalized five people and resulted in three deaths between late July and December 2023.
The Pittsburgh Post-Gazette (Hayes, J.) 12.03.2023, published “Reproductive anomaly enables a tick species to race into Pennsylvania.” The Asian longhorned tick, a parasite from Southeast Asia, is posing a significant threat to livestock, wildlife, and pets across 19 states, including Pennsylvania. This invasive species, known for reproducing asexually, has rapidly spread since its arrival in the United States in 2017 and has been confirmed in numerous Pennsylvania counties and city parks.
5 On Your Side (Bassler, H.) 11.22.2023, published “A sesame seed-sized tick is spreading across Missouri. Here’s what to know.” The article discusses the spread of various tick-borne diseases in Missouri, particularly due to the invasive Asian longhorned tick. This tick was first reported in the U.S. in 2017, but potentially present since before 2010. It has been detected across multiple states and is known for transmitting diseases like anaplasmosis, babesiosis, ehrlichiosis, […]
The Mary Ann Liebert, Inc. (McClung, K.L., et al.) 11.01.2023, published “Seasonality of Amblyomma americanum (Acari: Ixodidae) Activity and Prevalence of Infection with Tick-Borne Disease Agents in North Central Oklahoma.” This article discusses a study focused on Amblyomma americanum, a common tick in the southern United States, and its transmission of diseases to humans and animals.
The Journal of Allergy and Clinical Immunology: In Practice (Ailsworth SM., et al.) 10.31.2023, published “Alpha-gal IgE Prevalence Patterns in the United States: An Investigation of 3000 Military Recruits”. This article investigates Alpha-gal syndrome (AGS), an allergy to mammalian meat, particularly associated with bites from lone star ticks (Amblyomma americanum).
New York Post, 11.3.2023, published “Tiny, cattle-killing ticks spread across Ohio: ‘No getting rid of them.’” The article, which includes a video, covers a recent study from Ohio State University warning of the danger of Asian longhorned ticks (Acari: Ixodidae: Haemaphysalis longicornis Neumann).
The Tribune Democrat, Russ O’Reilly, reported on 10.13.2023, “UPJ scientists win grants to develop new tick repellent.” As reported, researchers will be using $100,000 won through the “Pitt Innovation Challenge” to make a novel and commercially available tick repellant (B.I.T.E.) that works by masking carbon dioxide emitted through human skin so that ticks can not detect these emissions.
The DailyMail.com (Luke Andrews) 09.26.2023, has reported in an exclusive news article “Experimental Lyme disease pill laces your skin with poison – killing parasites before they infect.” Tarsus Pharmaceuticals, a California-based company has developed an experimental drug that will kill ticks that bite human skin.
The Parasites & Vectors Journal (Arahirwa V., et al.) 08.24.2023, published “Impact of the COVID-19 pandemic on delays in diagnosis and treatment of tick-borne diseases endemic to southeastern USA.” This article talks about how the COVID-19 pandemic affected the diagnosis and treatment of diseases transmitted by ticks, like Lyme disease.
The COVID-19 pandemic caused delays in diagnosing and treating various medical conditions. The impact this has on tick-borne diseases, which can have symptoms similar to COVID-19, hasn’t been well understood. This study looked at patients with suspected tick-borne diseases before and after COVID-19 to see if there were delays in diagnosing and treating these diseases during the pandemic.
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.
Some providers may not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. Contact the provider to confirm.
It is your responsibility to contact the provider’s office to confirm the current address, directions, nature of services provided, and all other provider information before you make an appointment.
DISCLAIMER: The Lyme Disease Association, Inc. provides referrals to health care providers who treat Lyme disease, and often other TBD, as a courtesy to those seeking Lyme Literate Physicians (LLMD). However, some of the providers included do not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. We do not evaluate the professional competence or qualifications of health care providers on our referral list or the costs of services provided. Accordingly, the LDA neither warrants nor endorses the health care providers contained on this list nor the quality of care you will receive from those providers. We do not make recommendations, only referrals. LDA does not receive any monies from physicians to be included on this list nor does LDA provide any monies to physicians. Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines: Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the Doctor Referral System contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the zip code entered and category/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of.
LDA does not accept or reply to any comments on:
We cannot guarantee that the information provided will be timely and accurate or that physicians on the list are accepting new patients, or that they accept insurance. The selection of a physician should be made by you after careful consideration. There are two approaches in the treatment of Lyme disease. Our list contains physicians who generally follow more flexible treatment approaches than those advocated by the Infectious Diseases Society of America (IDSA). LDA is not responsible for incorrect information on the website. BEFORE DOCTOR VISIT: Please contact the physicians’ offices directly to confirm their current address, directions, and any other necessary information before scheduling an appointment. Do not rely only on the maps provided on this site. The maps on LDA’s Doctor Referral System are for informational purposes and provide an approximate locality of the listing based on the addresses we are provided with at the time of site updates. Practitioners often relocate and addresses can change. Notification of changes in listed information can be updated on our Dr. Referral Contact Form. Thank you, Lyme Disease Association, Inc. (LDA)
Subscriber information will not be shared outside of the Lyme Disease Association, Inc. nor used for donor solicitation.
The Lyme Disease Association, Inc. reserves the right to unsubscribe anyone from this service without cause.